iQX Limited 2017 Annual Report
Preliminary Final Report FY 2017
40024 NSX Nominated Adviser’s Declaration – Nominated Adviser’s Declaration
Series 8 – Unconditional Registration Announcement
Change in Auditor Notice
Extension of Private Placement
Final iQX Half Yearly Report 31 Dec 2016
Results of 2016 Annual General Meeting
Glucose Biosensor Systems – NASDAQ listing
40031 NSX Trading Halt Status – Removal of Trading Halt
